Search

Search Constraints

You searched for: Author/Creator Lin, C-C

Search Results

1. 1159PPhase I/II study of spartalizumab (PDR001), an anti-PD1 mAb, in patients with advanced melanoma or non-small cell lung cancer. (23rd October 2018)

2. 1288PSafety and efficacy of anti-PD-1 inhibitor ABBV-181 in lung and head and neck carcinoma. (1st October 2019)

4. 1399PImpact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC). (23rd October 2018)

5. 1452PCombination of the S49076 with gefitinib in NSCLC patients progressing on EGFR-TKI and harboring MET/AXL dysregulation. (23rd October 2018)

6. 438PSafety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891. (23rd October 2018)

8. 531PThe clinical features and genomic landscape of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in patients with colorectal cancer. (23rd October 2018)

10. 70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors. (17th December 2018)